Self-reported HIV testing and treatment among migrants from northeast South Africa: A cross-sectional, population-based analysis [0.03%]
南非东北部移民的自我报告艾滋病毒检测和治疗情况：一项基于人口的横断面分析
Rachel R Yorlets,F Xavier Goméz-Olivé,Carren Ginsburg et al.
Rachel R Yorlets et al.
Southern African HIV Clinicians Society guideline on pre-exposure prophylaxis to prevent HIV [0.03%]
南部非洲艾滋病临床医生协会关于使用暴露前预防措施以防止艾滋病的指南
Pippa Macdonald,Gonasagrie Nair,Camilla Wattrus et al.
Pippa Macdonald et al.
Delivery models of HIV pre-exposure prophylaxis and their influence on uptake in South Africa: An integrative review [0.03%]
南非HIV暴露前预防给药模式及其对服用率的影响：整合型综述
Junior M Ntimani,Andile G Mokoena-de Beer,Deliwe R Phetlhu
Junior M Ntimani
Background: Maximising the use of HIV pre-exposure prophylaxis (PrEP) is crucial to eliminate new HIV transmissions, especially in high-prevalence areas such as South Africa. Strengthening access and acceptability of PrEP...
Blood and urine early treatment response biomarkers in HIV-associated disseminated tuberculosis [0.03%]
与艾滋病相关的播散性肺结核的早期治疗反应生物标志物研究：血和尿中的生物标志物检测
Linda Boloko,Marcia Vermeulen,Bianca Sossen et al.
Linda Boloko et al.
Background: Treatment response biomarkers are needed in the care of patients hospitalised with HIV-associated tuberculosis (TB). Objectives: ...
Longer-term virologic outcomes on tenofovir-lamivudine-dolutegravir in second-line ART [0.03%]
新一代二联复方单片制剂替诺福韦拉米夫定多替拉韦用于二线抗病毒治疗的长期疗效：扩展分析结果
Jennifer K van Heerden,Ying Zhao,Claire M Keene et al.
Jennifer K van Heerden et al.
Background: Dolutegravir in second-line antiretroviral therapy (ART) is more effective with recycled tenofovir than switching to zidovudine. However, dolutegravir resistance is more frequent in second-line compared to fir...
Rapid emergence of dolutegravir resistance on second-line dolutegravir-based ART [0.03%]
多替拉韦单药作为二线抗病毒治疗后快速产生耐药性
Kirusha Naidoo,Richard J Lessells,Jienchi Dorward et al.
Kirusha Naidoo et al.
The integrase strand transfer inhibitor, dolutegravir (DTG), is widely used in first- and second-line antiretroviral therapy (ART) regimens in South Africa. We describe an adult with virological failure on second-line tenofovir/lamivudine/d...
Tracking viral control in adolescents on antiretroviral therapy in Lusaka, Zambia: A retrospective cohort analysis [0.03%]
一项回顾性队列分析：卢萨卡接受抗逆转录病毒治疗的青少年中的病毒抑制情况追踪研究
Kaala Moomba,Talitha Crowley,Brian van Wyk
Kaala Moomba
Background: In 2023, an estimated 39.9 million people globally were living with HIV, of which 1.55 million were adolescents aged 10-19 years. The 2021 Zambia HIV Impact Assessment revealed lower viral suppression rates in...
Transition of adolescents from paediatric to adult HIV care in South Africa: A policy review [0.03%]
南非艾滋病青少年患者从儿科到成人科的过渡：一项政策回顾
Charné Petinger,Talitha Crowley,Brian van Wyk
Charné Petinger
The successful roll-out and improved delivery of antiretroviral therapy (ART) services has led to paediatric HIV patients surviving to reach adolescence. Adolescents living with HIV (ALHIV) are challenged when transitioning to adult HIV car...
Barriers and facilitators of HIV treatment services among men who have sex with men during COVID-19 lockdown [0.03%]
新冠肺炎疫情期间阻碍和促进男男性行为者使用HIV治疗服务的因素分析
Betty Sebati,Edith Phalane,Amukelani Bilankulu et al.
Betty Sebati et al.
Background: The provision of HIV treatment services was severely impacted by the COVID-19 pandemic and the subsequent lockdown measures, particularly among men who have sex with men (MSM), a population disproportionately ...
Reflexed cryptococcal antigenaemia detection rates in the Western Cape, South Africa [0.03%]
南非西开普省曲霉抗原血症的反射检测率
Naseem Cassim,Manuel P da Silva,Lindi-Marie Coetzee
Naseem Cassim
Background: Reflexed cryptococcal antigenaemia (CrAg) testing has been offered on remnant CD4 specimens with a count < 100 cells/µL from 2017 in South Africa. The Western Cape is the only province to introduce CrAg testi...